We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
RBM33
  • TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

RBM33

Gene description

RNA binding motif protein 33

Protein class

Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

8
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Expressed in all
HPA (normal tissue):Expressed in all

Protein evidence

Evidence at protein level

Protein expression
normal tissue

General nuclear and cytoplasmic expression.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data. Pending external verification.

Reliability score

Approved based on 3 antibodies.
HPA019232 , HPA021497 , HPA021768
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in head and neck cancer (favourable), renal cancer (unfavourable) and urothelial cancer (favourable).
Head and neck cancer p<0.001
Renal cancer p<0.001
Urothelial cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer

STAINING SUMMARY

HPA019232
HPA021497
HPA021768

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

A majority of cancers exhibited moderate cytoplasmic staining. Strong immunoreactivity in a granular pattern was seen in most thyroid cancers and several cases of malignant gliomas and lymphomas. A majority of skin and cervical cancers were in negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most malignancies were weakly stained or negative. Urothelial cancers and a majority of colorectal, breast, testicular and liver cancers displayed moderate cytoplasmic staining. Glial cells as well as malignant gliomas, malignant lymphomas, thyroid, lung and renal cancers were negative in most cases.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Malignant tissues were in most cases weakly stained or negative. Moderate to strong cytoplasmic and/or nuclear immunoreactivity was observed in cases of malignant lymphoma, glioma, ovarian, breast, colorectal, testicular and liver cancers.

GENE INFORMATION

Gene name

RBM33 (HGNC Symbol)

Synonyms

DKFZp434D1319, DKFZp686F102, MGC20460, PRR8

Description

RNA binding motif protein 33 (HGNC Symbol)

Entrez gene summary

Chromosome

7

Cytoband

q36.3

Chromosome location (bp)

155644451 - 155781485

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000184863 (version 83.38)

Entrez gene

155435

UniProt

Q96EV2 (UniProt - Evidence at protein level)

neXtProt

NX_Q96EV2

Antibodypedia

RBM33 antibodies

PROTEIN BROWSER

RBM33-001
RBM33-002
RBM33-003
RBM33-004
RBM33-005
RBM33-007
RBM33-008
RBM33-010

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

RBM33-001
ENSP00000341583
ENST00000341148
A0A0C4DFS3 [Direct mapping]
RNA-binding protein 33
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0003676 [nucleic acid binding]
Show all
106 aa
11.7 kDa
No 0
RBM33-002
ENSP00000405793
ENST00000438356
C9J7M3 [Direct mapping]
RNA-binding protein 33
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
28 aa
3.1 kDa
No 0
RBM33-003
ENSP00000376514
ENST00000392761
H0Y3K4 [Direct mapping]
RNA-binding protein 33
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
909 aa
100.2 kDa
No 0
RBM33-004
ENSP00000376510
ENST00000392755
H0Y3K3 [Direct mapping]
RNA-binding protein 33
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0003676 [nucleic acid binding]
Show all
84 aa
8.8 kDa
No 0
RBM33-005
ENSP00000376513
ENST00000392759
A8MTF7 [Direct mapping]
RNA-binding protein 33
Show all
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
308 aa
34.7 kDa
No 0
RBM33-007
ENSP00000384160
ENST00000401878
Q96EV2 [Direct mapping]
RNA-binding protein 33
Show all
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0003676 [nucleic acid binding]
GO:0044822 [poly(A) RNA binding]
Show all
1170 aa
130 kDa
No 0
RBM33-008
ENSP00000287912
ENST00000287912
Q96EV2 [Direct mapping]
RNA-binding protein 33
Show all
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000166 [nucleotide binding]
GO:0044822 [poly(A) RNA binding]
Show all
268 aa
30.2 kDa
No 0
RBM33-010
ENSP00000394987
ENST00000440108
H7C0H2 [Direct mapping]
RNA-binding protein 33
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
342 aa
39 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.